What one share of PTC Therapeutics holds
We are a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. We are advancing a robust and diversified pipeline of transformative medicines as part of our mission to provide access to best-in-class treatments for patients with unmet medical needs.
PTC Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.09 |
|---|---|
| Profit | −$0.38 |
| Capex (buildings and equipment) | $0.10 |
| Free cash flow | −$0.44 |
| Cash and investments | $26.75 |
| Debt | $7.16 |
| Book value | −$1.98 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | $2.70 | −$5.18 | $0.07 | −$3.72 | — | — |
| 2014 | $0.80 | −$2.97 | $0.15 | −$1.96 | — | — |
| 2015 | $1.09 | −$5.07 | $0.08 | −$3.78 | — | — |
| 2016 | $2.43 | −$4.17 | $0.05 | −$3.09 | — | — |
| 2017 | $4.96 | −$2.02 | $0.08 | −$0.34 | — | — |
| 2018 | $5.68 | −$2.75 | $0.15 | −$0.75 | — | — |
| 2019 | $5.22 | −$4.27 | $0.23 | −$1.91 | — | — |
| 2020 | $5.77 | −$6.64 | $0.27 | −$3.21 | — | — |
| 2021 | $7.64 | −$7.43 | $0.40 | −$3.97 | — | $0.02 |
| 2022 | $9.74 | −$7.79 | $0.45 | −$5.42 | — | −$4.75 |
| 2023 | $12.53 | −$8.37 | $0.38 | −$2.50 | — | −$10.81 |
| 2024 | $10.50 | −$4.73 | $0.08 | −$1.49 | — | −$14.13 |
| 2025 | $19.60 | $7.78 | $0.10 | $7.95 | — | −$2.52 |
Common questions about PTC Therapeutics
How much does one share of PTC Therapeutics earn?
Over the last 12 months, PTC Therapeutics lost $0.38 for each share on $11.09 of sales.
Does PTC Therapeutics pay a dividend?
PTC Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is PTC Therapeutics’s book value per share?
PTC Therapeutics’s book value is negative (−$1.98 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of PTC Therapeutics have?
Each share of PTC Therapeutics has $26.75 of cash and investments and $7.16 of debt, as of June 30, 2026.
What is PTC Therapeutics’s free cash flow per share?
−$0.44 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has PTC Therapeutics bought back shares?
PTC Therapeutics’s share count rose about 588% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.